Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Digestive System Disorders | Discovery | - | 06 Jun 2024 | |
Drug-Related Side Effects and Adverse Reactions | Discovery | - | 06 Jun 2024 | |
Endocrinology and Metabolic Disease | Discovery | - | 06 Jun 2024 | |
Immune System Diseases | Discovery | - | 06 Jun 2024 | |
Infectious Diseases | Discovery | - | 06 Jun 2024 | |
Inflammation | Discovery | - | 06 Jun 2024 | |
Neoplasms | Discovery | - | 06 Jun 2024 | |
Nerve Degeneration | Discovery | - | 06 Jun 2024 | |
Rare Diseases | Discovery | - | 06 Jun 2024 | |
Skin and Musculoskeletal Diseases | Discovery | - | 06 Jun 2024 |